One major warning sign of osteoporosis is a “fragility fracture”—a broken bone caused by something minor like a simple fall.

For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...

BIDMC investigator Mary Bouxsein helped secure FDA approval of bone density imaging as a faster endpoint for osteoporosis ...

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a ...

The study included 44,338 matched pairs of patients who were treated with bisphosphonates, denosumab, raloxifene, or teriparatide and those who did not receive any of these treatments. HealthDay News ...

Millions of osteoporosis patients worldwide are set to benefit from a major international breakthrough, which will transform ...

Scientists at Pompeu Fabra University (UPF) have made a great leap forward in predicting the risk of hip fracture among women ...

Osteoporosis treatment was associated with lower mortality and hospitalization rates among people older than 80 who had suffered fractures, according to a study presented at the Endocrine Society’s ...